Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Liang W, et al. Among authors: xu k. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14. Lancet Oncol. 2020. PMID: 32066541 Free PMC article. No abstract available.
Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung cancer: A systematic review and network meta-analysis.
Zhao Y, Cheng B, Chen Z, Li J, Liang H, Chen Y, Zhu F, Li C, Xu K, Xiong S, Lu W, Chen Z, Zhong R, Zhao S, Xie Z, Liu J, Liang W, He J. Zhao Y, et al. Among authors: xu k. Crit Rev Oncol Hematol. 2021 Apr;160:103305. doi: 10.1016/j.critrevonc.2021.103305. Epub 2021 Mar 20. Crit Rev Oncol Hematol. 2021. PMID: 33757838 Review.
Potential of the glasses-free three-dimensional display system in shortening the learning curve of video-assisted endoscopic surgery: a self-controlled ex-vivo study.
Liu J, Li J, Wei W, Hao Z, Liang H, Cui F, Wang W, Huang J, Peng G, Huang W, Wang Y, Lai F, He K, Pan Q, Xu K, Cai W, Hamblin L, Liang W, He J. Liu J, et al. Among authors: xu k. Ann Transl Med. 2019 Oct;7(20):521. doi: 10.21037/atm.2019.10.01. Ann Transl Med. 2019. PMID: 31807503 Free PMC article.
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study.
Liu J, Li J, Lin W, Shao D, Depypere L, Zhang Z, Li Z, Cui F, Du Z, Zeng Y, Jiang S, He P, Gu X, Chen H, Zhang H, Lin X, Huang H, Lv W, Cai W, Liang W, Liang H, Jiang W, Wang W, Xu K, Cai W, Wu K, Lerut T, Fu J, He J. Liu J, et al. Among authors: xu k. Int J Cancer. 2022 Jul 1;151(1):128-137. doi: 10.1002/ijc.33976. Epub 2022 Mar 21. Int J Cancer. 2022. PMID: 35188268 Free article. Clinical Trial.
11,449 results
You have reached the last available page of results. Please see the User Guide for more information.